James E Egan

Summary

Affiliation: New York Academy of Medicine
Country: USA

Publications

  1. ncbi The Physician Clinical Support System-Buprenorphine (PCSS-B): a novel project to expand/improve buprenorphine treatment
    James E Egan
    New York Academy of Medicine, 1216 5th Avenue, New York, NY 10029, USA
    J Gen Intern Med 25:936-41. 2010
  2. ncbi Patient perspectives on buprenorphine/naloxone treatment in the context of HIV care
    James E Egan
    The New York Academy of Medicine, Center for Evaluation and Applied Research, 1216 5th Avenue, New York, NY 10029, USA
    J Acquir Immune Defic Syndr 56:S46-53. 2011
  3. ncbi Sociodemographic and risk behavior characteristics associated with unprotected sex with women among black men who have sex with men and women in New York City
    Hong Van Tieu
    Laboratory of Infectious Disease Prevention, Lindsley F Kimball Research Institute, New York Blood Center, New York, NY, USA
    AIDS Care 24:1111-9. 2012
  4. ncbi Integration of buprenorphine/naloxone treatment into HIV clinical care: lessons from the BHIVES collaborative
    Linda Weiss
    The New York Academy of Medicine, Center for Evaluation and Applied Research, New York, NY 10029, USA
    J Acquir Immune Defic Syndr 56:S68-75. 2011
  5. ncbi The BHIVES collaborative: organization and evaluation of a multisite demonstration of integrated buprenorphine/naloxone and HIV treatment
    Linda Weiss
    The New York Academy of Medicine, Center for Evaluation and Applied Research, New York, NY 10029, USA
    J Acquir Immune Defic Syndr 56:S7-13. 2011
  6. ncbi The cost of integrated HIV care and buprenorphine/naloxone treatment: results of a cross-site evaluation
    Bruce R Schackman
    Department of Public Health, Weill Cornell Medical College, New York, NY 10065, USA
    J Acquir Immune Defic Syndr 56:S76-82. 2011
  7. ncbi Factors affecting willingness to provide buprenorphine treatment
    Julie Netherland
    The New York Academy of Medicine, Division of Health Policy, New York, NY 10029, USA
    J Subst Abuse Treat 36:244-51. 2009
  8. ncbi Sexual partner characteristics, serodiscordant/serostatus unknown unprotected anal intercourse and disclosure among human immunodeficiency virus-infected and uninfected black men who have sex with men in New York City
    Hong Van Tieu
    Laboratory of Infectious Disease Prevention, Lindsley F Kimball Research Institute, New York Blood Center, New York, NY, USA
    Sex Transm Dis 38:548-54. 2011
  9. ncbi Migration, neighborhoods, and networks: approaches to understanding how urban environmental conditions affect syndemic adverse health outcomes among gay, bisexual and other men who have sex with men
    James E Egan
    Center for Urban Epidemiologic Studies, The New York Academy of Medicine, New York, NY, USA
    AIDS Behav 15:S35-50. 2011

Detail Information

Publications9

  1. ncbi The Physician Clinical Support System-Buprenorphine (PCSS-B): a novel project to expand/improve buprenorphine treatment
    James E Egan
    New York Academy of Medicine, 1216 5th Avenue, New York, NY 10029, USA
    J Gen Intern Med 25:936-41. 2010
    ..The PCSS-B model provides support for a mentorship program to assist non-specialty physicians in the provision of buprenorphine and may serve as a model for dissemination of other types of care...
  2. ncbi Patient perspectives on buprenorphine/naloxone treatment in the context of HIV care
    James E Egan
    The New York Academy of Medicine, Center for Evaluation and Applied Research, 1216 5th Avenue, New York, NY 10029, USA
    J Acquir Immune Defic Syndr 56:S46-53. 2011
    ..Research has shown that buprenorphine/naloxone (bup/nx) is a safe and effective treatment for opioid dependence. Few reports, however, describe the patient perspective on bup/nx treatment and its integration into HIV care settings...
  3. ncbi Sociodemographic and risk behavior characteristics associated with unprotected sex with women among black men who have sex with men and women in New York City
    Hong Van Tieu
    Laboratory of Infectious Disease Prevention, Lindsley F Kimball Research Institute, New York Blood Center, New York, NY, USA
    AIDS Care 24:1111-9. 2012
    ..Disclosure of bisexuality to female partners may be an important component of future prevention efforts...
  4. ncbi Integration of buprenorphine/naloxone treatment into HIV clinical care: lessons from the BHIVES collaborative
    Linda Weiss
    The New York Academy of Medicine, Center for Evaluation and Applied Research, New York, NY 10029, USA
    J Acquir Immune Defic Syndr 56:S68-75. 2011
    ..The experiences of physicians leading the Buprenorphine HIV Evaluation and Support initiative provides valuable information for other HIV providers seeking to integrate medication-assisted treatment services into HIV clinical care...
  5. ncbi The BHIVES collaborative: organization and evaluation of a multisite demonstration of integrated buprenorphine/naloxone and HIV treatment
    Linda Weiss
    The New York Academy of Medicine, Center for Evaluation and Applied Research, New York, NY 10029, USA
    J Acquir Immune Defic Syndr 56:S7-13. 2011
    ..Although limitations to evaluation findings persist, they may be balanced by the scope and "real-world" context of the initiative...
  6. ncbi The cost of integrated HIV care and buprenorphine/naloxone treatment: results of a cross-site evaluation
    Bruce R Schackman
    Department of Public Health, Weill Cornell Medical College, New York, NY 10065, USA
    J Acquir Immune Defic Syndr 56:S76-82. 2011
    ..Implementing integrated HIV and buprenorphine/naloxone treatment requires cost estimates to plan and obtain funding...
  7. ncbi Factors affecting willingness to provide buprenorphine treatment
    Julie Netherland
    The New York Academy of Medicine, Division of Health Policy, New York, NY 10029, USA
    J Subst Abuse Treat 36:244-51. 2009
    ..These data provide important insight into physician concerns about buprenorphine and have implications for practice, education, and policy change that may effectively support widespread adoption of buprenorphine...
  8. ncbi Sexual partner characteristics, serodiscordant/serostatus unknown unprotected anal intercourse and disclosure among human immunodeficiency virus-infected and uninfected black men who have sex with men in New York City
    Hong Van Tieu
    Laboratory of Infectious Disease Prevention, Lindsley F Kimball Research Institute, New York Blood Center, New York, NY, USA
    Sex Transm Dis 38:548-54. 2011
    ..This study describes sexual partner characteristics and disclosure of HIV serostatus and evaluates factors associated with sexual risk behaviors during last sex among black MSM...
  9. ncbi Migration, neighborhoods, and networks: approaches to understanding how urban environmental conditions affect syndemic adverse health outcomes among gay, bisexual and other men who have sex with men
    James E Egan
    Center for Urban Epidemiologic Studies, The New York Academy of Medicine, New York, NY, USA
    AIDS Behav 15:S35-50. 2011
    ..Overall, these findings suggest the need for further investigation into the role of macro-level social forces on the emotional, behavioral, and physical health of urban MSM...